Thermogenesis and metabolic rate increase
Capsaicin activates TRPV1 receptors in brown adipose tissue and the enteric nervous system, triggering sympathetic nervous system stimulation and uncoupling protein 1 (UCP1) expression. Clinical studies show 50–200 kcal/day increase in energy expenditure with consistent capsaicin supplementation.
Fat oxidation and body composition
Multiple RCTs demonstrate capsaicin significantly increases fat oxidation (especially during exercise), reduces visceral adipose tissue, and improves fat-to-lean ratio over 8–12 weeks. Effects are non-stimulant and cardiovascular-neutral at clinical doses.
Appetite reduction and satiety
Capsaicin reduces appetite and increases feelings of fullness through GLP-1 and PYY hormone release, reduced ghrelin, and direct effects on the hypothalamic appetite center. Meta-analyses show ~74 kcal reduction in subsequent meal energy intake after capsaicin supplementation.
Exercise performance enhancement
Pre-exercise capsaicin supplementation improves peak power output, reduces perceived exertion (RPE), and extends time-to-exhaustion in trained athletes. Central desensitization to pain signals during exercise is a proposed additional mechanism.
Analgesic and anti-inflammatory effects
Topical capsaicin depletes substance P (pain neurotransmitter) from sensory neurons. Oral capsaicin also reduces systemic inflammatory markers (CRP, IL-6) and has been studied for pain relief in osteoarthritis, neuropathy, and cluster headaches.
TRPV1 receptor activation and thermogenesis
Capsaicin binds TRPV1 (transient receptor potential vanilloid 1) receptors in adipose tissue, gut, and hypothalamus. TRPV1 activation triggers calcium influx, sympathetic nervous system stimulation, and UCP1 upregulation in brown and beige adipocytes — generating heat by uncoupling mitochondrial respiration from ATP synthesis.
Catecholamine release and SNS activation
TRPV1 activation in the hypothalamus triggers norepinephrine and epinephrine release from the adrenal medulla, stimulating beta-3 adrenergic receptors in adipose tissue and increasing lipolysis, fatty acid oxidation, and metabolic rate without cardiovascular stimulant effects at clinical doses.
GLP-1 and satiety hormone modulation
Capsaicin stimulates L-cells in the intestinal mucosa to secrete glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), promoting satiety and reducing gastric emptying rate. Ghrelin (hunger hormone) is simultaneously suppressed, creating a multi-pathway reduction in caloric intake.
RCT of Capsimax® (4 mg capsaicinoids/day) vs. placebo in 75 overweight adults for 12 weeks combined with moderate caloric restriction.
75 overweight adults. 12-week intervention with diet.
Capsimax® group showed significantly greater reductions in body fat percentage, waist circumference, and visceral fat vs. placebo. Total weight loss enhanced by ~50% vs. diet alone. No GI side effects — distinguishing Capsimax® from standard capsaicin.
Meta-analysis of 20 RCTs examining capsaicin/capsicum supplementation on energy expenditure, fat oxidation, and appetite.
Pooled data from 20 RCTs in healthy and overweight adults.
Capsaicin supplementation significantly increased energy expenditure (+50 kcal/day average), increased fat oxidation, and reduced appetite. Effects were consistent across studies and significant for all three primary outcomes.
RCT examining capsaicin supplementation (12 mg) 45 minutes before cycling time trial in trained cyclists.
Trained male cyclists. Crossover design.
Capsaicin supplementation significantly improved 4 km cycling time trial performance and reduced perceived exertion (RPE) at equivalent workloads. Supports use as pre-workout ergogenic aid.